Evaluation of exacerbations and blood eosinophils in UK and US COPD populations

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations

Abstract Background Blood eosinophil counts and history of exacerbations have been proposed as predictors of patients with chronic obstructive pulmonary disease (COPD) who may benefit from triple therapy (inhaled corticosteroid, long-acting β2-agonist and long-acting muscarinic antagonist). Methods...

Full description

Bibliographic Details
Main Authors: Claus F. Vogelmeier, Konstantinos Kostikas, Juanzhi Fang, Hengfeng Tian, Bethan Jones, Christopher Ll Morgan, Robert Fogel, Florian S. Gutzwiller, Hui Cao
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Respiratory Research
Subjects:
COPD
Triple therapy
Eosinophil
Exacerbation
Online Access:http://link.springer.com/article/10.1186/s12931-019-1130-y

Internet

http://link.springer.com/article/10.1186/s12931-019-1130-y

Similar Items